Application Sponsors
Marketing Status
| Prescription | 001 |
| Prescription | 002 |
| Prescription | 003 |
| Prescription | 004 |
Application Products
| 001 | TABLET, ORALLY DISINTEGRATING;ORAL | 5MG | 0 | OLANZAPINE | OLANZAPINE |
| 002 | TABLET, ORALLY DISINTEGRATING;ORAL | 10MG | 0 | OLANZAPINE | OLANZAPINE |
| 003 | TABLET, ORALLY DISINTEGRATING;ORAL | 15MG | 0 | OLANZAPINE | OLANZAPINE |
| 004 | TABLET, ORALLY DISINTEGRATING;ORAL | 20MG | 0 | OLANZAPINE | OLANZAPINE |
FDA Submissions
| ORIG | 1 | AP | 2011-10-24 | |
| LABELING; Labeling | SUPPL | 3 | AP | 2022-07-08 | STANDARD |
| LABELING; Labeling | SUPPL | 6 | AP | 2022-07-08 | STANDARD |
| LABELING; Labeling | SUPPL | 10 | AP | 2022-07-08 | STANDARD |
| LABELING; Labeling | SUPPL | 12 | AP | 2022-07-08 | STANDARD |
| LABELING; Labeling | SUPPL | 13 | AP | 2022-07-08 | STANDARD |
| LABELING; Labeling | SUPPL | 15 | AP | 2022-07-08 | STANDARD |
Submissions Property Types
| ORIG | 1 | Null | 7 |
| SUPPL | 3 | Null | 7 |
| SUPPL | 6 | Null | 15 |
| SUPPL | 10 | Null | 15 |
| SUPPL | 12 | Null | 31 |
| SUPPL | 13 | Null | 15 |
| SUPPL | 15 | Null | 15 |
TE Codes
| 001 | Prescription | AB |
| 002 | Prescription | AB |
| 003 | Prescription | AB |
| 004 | Prescription | AB |
CDER Filings
APOTEX INC
cder:Array
(
[0] => Array
(
[ApplNo] => 91265
[companyName] => APOTEX INC
[docInserts] => ["",""]
[products] => [{"drugName":"OLANZAPINE","activeIngredients":"OLANZAPINE","strength":"5MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OLANZAPINE","activeIngredients":"OLANZAPINE","strength":"10MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OLANZAPINE","activeIngredients":"OLANZAPINE","strength":"15MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OLANZAPINE","activeIngredients":"OLANZAPINE","strength":"20MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"OLANZAPINE","submission":"OLANZAPINE","actionType":"5MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OLANZAPINE","submission":"OLANZAPINE","actionType":"10MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OLANZAPINE","submission":"OLANZAPINE","actionType":"15MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OLANZAPINE","submission":"OLANZAPINE","actionType":"20MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)